TREM2 is highly expressed on TAMs in a variety of cancers, including colorectal, triple-negative breast, and pancreatic cancers (15, 32–34), and is negatively correlated with survival, and is a pro-tumorigenic marker for TAMs in mouse models and human tumors. This evidence concerns the gene TREM2 and cancer.